It is shown here that by using specific autophagy inhibitors not only cancer cell proliferation rate can be reduced, but the otherwise resistant mutant BRAF colon cell lines to targeted BRAF agents, like PLX4720 (Vemurafenib), can be sensitised to apoptosis in a synergistic manner. The gene discussed is BRAF; the disease is cancer.